Press release
Subcutaneous Drug Delivery Devices Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Subcutaneous Drug Delivery Devices
What Is the Projected Growth of the Subcutaneous Drug Delivery Devices Market?
The subcutaneous drug delivery devices market size is projected to grow from $27.66 billion in 2024 to $29.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period is attributed to the increasing prevalence of chronic diseases, rising demand for self-administration of drugs, higher rates of diabetes and obesity, patient preference for convenient treatments, and the growing geriatric population.
The subcutaneous drug delivery devices market size is projected to reach $39.57 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.4%. This growth is driven by the expansion of the biologics and biosimilars market, increased adoption of wearable drug delivery systems, the rise of personalized medicine, improved healthcare reimbursement policies, and a growing
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723
What Are the Different Subcutaneous Drug Delivery Devices Market Segments?
The subcutaneous drug delivery devicesmarket covered in this report is segmented -
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) Pen Needles: Standard Pen Needles, Safety Pen Needles
3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp
What Are the Primary Drivers Shaping the Subcutaneous Drug Delivery Devices Market?
The rising prevalence of diabetes and cardiovascular diseases (CVD) is expected to fuel the growth of the subcutaneous drug delivery devices market. These chronic conditions, driven by factors like aging populations and unhealthy lifestyles, necessitate convenient and controlled drug delivery systems. The British Diabetic Association reported in April 2023 that 4.3 million people in the UK are living with diabetes, while the CDC highlighted in May 2024 that heart disease remains the leading cause of death in the U.S., underscoring the need for subcutaneous drug delivery devices.
Which Companies Are Leading in the Subcutaneous Drug Delivery Devices Market?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
What Trends Are Driving Growth in The Subcutaneous Drug Delivery Devices Market?
Companies in the subcutaneous drug delivery devices market are working on innovative products like miniature digital liquid flow sensors to enhance drug delivery precision and safety. These sensors measure liquid flow rates with high accuracy. For instance, in May 2024, Sensirion AG, a Swiss company, launched the SLD3x series sensor platform, featuring digital liquid flow sensors designed for large-scale medical device production. These sensors ensure precise dosing, occlusion detection, and monitoring, which enhances patient safety in subcutaneous drug delivery.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report
What Are the Top Revenue-Generating Geographies in the Subcutaneous Drug Delivery Devices Market?
North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Subcutaneous Drug Delivery Devices Market?
2. What is the CAGR expected in the Subcutaneous Drug Delivery Devices Market?
3. What Are the Key Innovations Transforming the Subcutaneous Drug Delivery Devices Industry?
4. Which Region Is Leading the Subcutaneous Drug Delivery Devices Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Subcutaneous Drug Delivery Devices Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4050660 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
